Malcolm A. Young

962 total citations
31 papers, 808 citations indexed

About

Malcolm A. Young is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Malcolm A. Young has authored 31 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Malcolm A. Young's work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Malcolm A. Young is often cited by papers focused on Diabetes Treatment and Management (11 papers), Diabetes Management and Research (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Malcolm A. Young collaborates with scholars based in United Kingdom, United States and Sweden. Malcolm A. Young's co-authors include Roman Hovorka, P.A. Soons, Jeffrey R. Koup, Edward J. Randinitis, Cho‐Ming Loi, Artemios B. Vassos, Jan Fawcett, William A. Scheftner, Sally Lettis and Louis Fogg and has published in prestigious journals such as American Journal of Psychiatry, Diabetologia and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Malcolm A. Young

31 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm A. Young United Kingdom 16 297 255 188 116 100 31 808
Yanling He China 18 338 1.1× 227 0.9× 161 0.9× 250 2.2× 99 1.0× 41 1.0k
AF Lant United Kingdom 18 199 0.7× 263 1.0× 131 0.7× 134 1.2× 68 0.7× 72 1.2k
Robert I. Misbin United States 20 415 1.4× 390 1.5× 258 1.4× 83 0.7× 49 0.5× 53 1.3k
Nasser Mikhail United States 18 453 1.5× 201 0.8× 265 1.4× 94 0.8× 24 0.2× 59 943
Bret J. Musser United States 14 689 2.3× 258 1.0× 257 1.4× 187 1.6× 46 0.5× 24 1.3k
Stephen D. Wise Singapore 16 228 0.8× 168 0.7× 128 0.7× 101 0.9× 244 2.4× 29 985
CK Ching Hong Kong 22 68 0.2× 273 1.1× 419 2.2× 67 0.6× 114 1.1× 75 1.3k
Karin Hedenmalm Sweden 15 96 0.3× 96 0.4× 103 0.5× 46 0.4× 110 1.1× 38 913
Luc Poirier Canada 21 309 1.0× 149 0.6× 168 0.9× 26 0.2× 42 0.4× 71 1.2k
Christopher S. Conner United States 16 676 2.3× 210 0.8× 148 0.8× 49 0.4× 44 0.4× 50 1.2k

Countries citing papers authored by Malcolm A. Young

Since Specialization
Citations

This map shows the geographic impact of Malcolm A. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm A. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm A. Young more than expected).

Fields of papers citing papers by Malcolm A. Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm A. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm A. Young. The network helps show where Malcolm A. Young may publish in the future.

Co-authorship network of co-authors of Malcolm A. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm A. Young. A scholar is included among the top collaborators of Malcolm A. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm A. Young. Malcolm A. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laffont, Céline M., Eliford Ngaimisi, Mathangi Gopalakrishnan, et al.. (2022). Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder. Frontiers in Pharmacology. 13. 1052113–1052113. 15 indexed citations
2.
3.
Wang, Hongyun, Dandan Li, Yongzhen Liu, et al.. (2019). Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder. Drugs in R&D. 19(3). 255–265. 12 indexed citations
4.
Darpö, Börje, Meijian Zhou, Jessica Matthews, et al.. (2014). Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study. Diabetes Therapy. 5(1). 141–153. 23 indexed citations
5.
Young, Malcolm A., Jeffrey A. Wald, Jessica Matthews, Fred Yang, & Rickey R. Reinhardt. (2014). Effect of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Albiglutide. Postgraduate Medicine. 126(3). 35–46. 22 indexed citations
6.
Young, Malcolm A., Jeffrey A. Wald, Jessica Matthews, et al.. (2014). Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist. Postgraduate Medicine. 126(7). 84–97. 30 indexed citations
7.
Beaumont, Claire, et al.. (2014). Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches. British Journal of Clinical Pharmacology. 78(6). 1185–1200. 45 indexed citations
8.
Ogungbenro, Kayode, Lakshmi Vasist, Robert MacLaren, et al.. (2010). A Semi-mechanistic Gastric Emptying Model for the Population Pharmacokinetic Analysis of Orally Administered Acetaminophen in Critically Ill Patients. Pharmaceutical Research. 28(2). 394–404. 7 indexed citations
9.
Schmith, Virginia D., Brendan M. Johnson, Lakshmi Vasist, et al.. (2009). The Effects of a Short Course of Antibiotics on Alvimopan and Metabolite Pharmacokinetics. The Journal of Clinical Pharmacology. 50(3). 338–349. 2 indexed citations
10.
Scannell, Ralph T., Xiong Cai, Joseph Eckman, et al.. (2004). Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H1 receptor antagonist properties. Inflammation Research. 53(0). S33–S34. 1 indexed citations
11.
Loi, Cho‐Ming, Malcolm A. Young, Edward J. Randinitis, Artemios B. Vassos, & Jeffrey R. Koup. (1999). Clinical Pharmacokinetics of Troglitazone. Clinical Pharmacokinetics. 37(2). 91–104. 103 indexed citations
12.
Young, Malcolm A., D.J.A. Eckland, R. Eastmond, & Sally Lettis. (1998). Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients. Annals of Medicine. 30(2). 206–212. 11 indexed citations
13.
Young, Malcolm A., Sally Lettis, & R. Eastmond. (1998). Concomitant administration of cholestyramine influences the absorption of troglitazone. British Journal of Clinical Pharmacology. 45(1). 37–40. 15 indexed citations
14.
Hovorka, Roman, et al.. (1998). Measuring prehepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule. Diabetologia. 41(5). 548–554. 48 indexed citations
15.
Hovorka, Roman, et al.. (1998). Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test. Diabetic Medicine. 15(3). 234–246. 14 indexed citations
16.
Ott, Peter, L Ranek, & Malcolm A. Young. (1998). Pharmacokinetics of troglitazone, a PPAR-γ agonist, in patients with hepatic insufficiency. European Journal of Clinical Pharmacology. 54(7). 567–571. 33 indexed citations
17.
Young, Malcolm A., Sally Lettis, & R. Eastmond. (1998). Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after, food. British Journal of Clinical Pharmacology. 45(1). 31–35. 20 indexed citations
18.
Loi, Cho‐Ming, Christine Alvey, Edward J. Randinitis, et al.. (1997). Meta‐Analysis of Steady‐State Pharmacokinetics of Troglitazone and Its Metabolites. The Journal of Clinical Pharmacology. 37(11). 1038–1047. 22 indexed citations
19.
Hovorka, Roman, P.A. Soons, & Malcolm A. Young. (1996). ISEC: a program to calculate insulin secretion. Computer Methods and Programs in Biomedicine. 50(3). 253–264. 152 indexed citations
20.
Young, Malcolm A., Louis Fogg, William A. Scheftner, & Jan Fawcett. (1994). Interactions of risk factors in predicting suicide. American Journal of Psychiatry. 151(3). 434–435. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanling He Breakdown of academic impact, for papers by AF Lant Breakdown of academic impact, for papers by Robert I. Misbin Breakdown of academic impact, for papers by Nasser Mikhail Breakdown of academic impact, for papers by Bret J. Musser Breakdown of academic impact, for papers by Stephen D. Wise Breakdown of academic impact, for papers by CK Ching Breakdown of academic impact, for papers by Karin Hedenmalm Breakdown of academic impact, for papers by Luc Poirier Breakdown of academic impact, for papers by Christopher S. Conner
Rankless by CCL
2026